Studies evaluating serum irisin levels in individuals with obesity have mostly shown a relationship between high irisin levels and a decreased risk of associated comorbidities, such as type 2 diabetes mellitus and other cardiometabolic disorders. The gene discussed is FNDC5; the disease is obesity disorder.